HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abnormal lipid droplets accumulation induced cognitive deficits in obstructive sleep apnea syndrome mice via JNK/SREBP/ACC pathway but not through PDP1/PDC pathway.

Abstract
The mechanisms of chronic intermittent hypoxia (CIH)-induced cognitive deficits remain unclear. Here, our study found that about 3 months CIH treatment induced lipid droplets (LDs) accumulation in hippocampal nerve and glia cells of C57BL/6 mice, and caused severe neuro damage including neuron lesions, neuroblast (NB) apoptosis and abnormal glial activation. Studies have shown that the neuronal metabolism disorders might contribute to the CIH induced-hippocampal impairment. Mechanistically, the results showed that pyruvate dehydrogenase complex E1ɑ subunit (PDHA1) and the pyruvate dehydrogenase complex (PDC) activator pyruvate dehydrogenase phosphatase 1 (PDP1) did not noticeable change after intermittent hypoxia. Consistent with those results, the level of Acetyl-CoA in hippocampus did not significantly change after CIH exposure. Interestingly, we found that CIH produced large quantities of ROS, which activated the JNK/SREBP/ACC pathway in nerve and glia cells. ACC catalyzed the carboxylation of Acetyl-CoA to malonyl-CoA and then more lipid acids were synthesized, which finally caused aberrant LDs accumulation. Therefore, the JNK/SREBP/ACC pathway played a crucial role in the cognitive deficits caused by LDs accumulation after CIH exposure. Additionally, LDs were peroxidized by the high level of ROS under CIH conditions. Together, lipid metabolic disorders contributed to nerve and glia cells damage, which ultimately caused behavioral dysfunction. An active component of Salvia miltiorrhiza, SMND-309, dramatically alleviated these injuries and improved cognitive deficits of CIH mice.
AuthorsDongze Li, Na Xu, Yanyan Hou, Wenjing Ren, Na Zhang, Xi Wang, Yeying Sun, Wenxue Lu, Guiwu Qu, Yan Yu, Changjun Lv, Fang Han
JournalMolecular medicine (Cambridge, Mass.) (Mol Med) Vol. 28 Issue 1 Pg. 3 (01 14 2022) ISSN: 1528-3658 [Electronic] England
PMID35030992 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s).
Chemical References
  • 2-(6-(2-carboxyvinyl)-2,3-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)acrylic acid
  • Caffeic Acids
  • Eye Proteins
  • GTP-Binding Protein Regulators
  • Phosphoproteins
  • Reactive Oxygen Species
  • Sterol Regulatory Element Binding Proteins
  • phosducin
  • Pdp1 protein, mouse
  • Protein Phosphatase 2C
  • Acetyl-CoA Carboxylase
Topics
  • Acetyl-CoA Carboxylase (metabolism)
  • Animals
  • Caffeic Acids (pharmacology)
  • Cognition
  • Cognitive Dysfunction
  • Disease Models, Animal
  • Eye Proteins (metabolism)
  • GTP-Binding Protein Regulators (metabolism)
  • Hippocampus (metabolism)
  • Hypoxia (metabolism)
  • Learning
  • Lipid Droplets (metabolism)
  • Lipid Peroxidation
  • MAP Kinase Signaling System
  • Memory
  • Mice
  • Neurons
  • Phosphoproteins (metabolism)
  • Protein Phosphatase 2C (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction
  • Sleep Apnea, Obstructive (diagnosis, drug therapy, etiology, metabolism)
  • Sterol Regulatory Element Binding Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: